Show simple item record

dc.contributor.authorKadowaki, D.
dc.contributor.authorSumikawa, S.
dc.contributor.authorArimizu, K.
dc.contributor.authorTaguchi, K.
dc.contributor.authorKitamura, K.
dc.contributor.authorIshitsuka, Y.
dc.contributor.authorNarita, Y.
dc.contributor.authorIrie, T.
dc.contributor.authorChuang, Victor
dc.contributor.authorMaruyama, T.
dc.contributor.authorOtagiri, M.
dc.contributor.authorHirata, S.
dc.date.accessioned2017-01-30T10:52:06Z
dc.date.available2017-01-30T10:52:06Z
dc.date.created2016-09-22T12:29:02Z
dc.date.issued2012
dc.identifier.citationKadowaki, D. and Sumikawa, S. and Arimizu, K. and Taguchi, K. and Kitamura, K. and Ishitsuka, Y. and Narita, Y. et al. 2012. Effect of acetaminophen on the progression of renal damage in adenine induced renal failure model rats. Life Sciences. 91: pp. 1304-1308.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/6318
dc.identifier.doi10.1016/j.lfs.2012.09.018
dc.description.abstract

Aims: Acetaminophen is a safe antipyretic and analgesic drug within the clinically recommended dosage range, but overdose can cause fatal liver and or kidney damage. Most of the nonsteroidal anti-inflammatory drugs (NSAIDs) exert their analgesic effect via inhibition of cyclooxygenase, which also results in a reduction of renal blood flow. Therefore, the use of NSAIDs in pain treatment for chronic kidney disease (CKD) patients is of particular concern. Acetaminophen lacks the anti-inflammatory and anti-coagulatory properties of the NSAIDs. In this study, we investigate whether acetaminophen has an impact on the progression of renal failure. Main methods: Acetaminophen (150 mg/kg/day or 750 mg/kg/day) or indomethacin (5 mg/kg/day) was orally administered to adenine-induced chronic renal failure model rats for 4 weeks. The plasma concentrations of acetaminophen and its metabolites were measured during the treatment period; renal function and oxidative stress in the rats were also monitored. Key findings: Indomethacin significantly decreased the survival rate of renal failure model rats. In contrast, both low (150 mg/kg) and high (750 mg/kg) doses of acetaminophen improved the survival rate. The progression of renal failure was attenuated by acetaminophen (750 mg/kg) after administration for 2 weeks. The metabolites of acetaminophen were found to accumulate in plasma. Plasma glutathione concentration had significantly recovered after acetaminophen administration. Significance: Acetaminophen has no effect on the progression of renal damage in adenine-induced renal failure model rats. This result is in part due to acetaminophen's antioxidant activity. These results suggest that acetaminophen is a suitable analgesic agent for treating CKD patients.

dc.publisherElsevier
dc.titleEffect of acetaminophen on the progression of renal damage in adenine induced renal failure model rats
dc.typeJournal Article
dcterms.source.volume91
dcterms.source.startPage1304
dcterms.source.endPage1308
dcterms.source.issn0024-3205
dcterms.source.titleLife Sciences
curtin.departmentSchool of Pharmacy
curtin.accessStatusFulltext not available


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record